Celltrion (XKRX:068270) Marketable Securities : ₩173,164 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Celltrion Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Celltrion's Marketable Securities for the quarter that ended in Mar. 2024 was ₩173,164 Mil.

Celltrion's annual Marketable Securities increased from Dec. 2021 (₩31,575 Mil) to Dec. 2022 (₩43,277 Mil) and increased from Dec. 2022 (₩43,277 Mil) to Dec. 2023 (₩192,885 Mil).

Celltrion Marketable Securities Historical Data

The historical data trend for Celltrion's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Marketable Securities Chart

Celltrion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

81,681.59

14,034.38

31,575.00

43,277.10

192,885.35

Celltrion Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															41,575.00	46,052.96	43,050.56	192,885.35	173,164.31

Celltrion Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Celltrion (XKRX:068270) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Celltrion Marketable Securities Related Terms

Thank you for viewing the detailed overview of Celltrion's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Celltrion (XKRX:068270) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840

Website

http://www.celltrion.com

Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines